Smith Jason Drew Insider Trading Activity
Smith Jason Drew has been net-selling over the last 12 months with 0 purchases and 5 sales across 1 company.
URGN is the most-traded position with 5 trades. The largest single transaction was a sale of URGN for $144K on Jul 28, 2025.
Performance Scorecard
Forward stock performance after each transaction by Smith Jason Drew. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +1.7% | 80% | 5 |
| 90 days | — | -16.9% | 0% | 5 |
| 120 days | — | -32.9% | 0% | 5 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersURGN · UroGen Pharma Ltd.
🔒 Subscribe to see trade entries
Pro members see exactly when Smith Jason Drew bought and sold URGN.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Feb 3, 2026 ⚠ Filed 6d late | URGN | Sell | 2,654 | $19.69 | $52K | −4.8% | General Counsel | |
Feb 3, 2026 ⚠ Filed 6d late | URGN | Sell | 1,608 | $19.69 | $32K | −3.0% | General Counsel | |
Feb 3, 2026 ⚠ Filed 6d late | URGN | Sell | 3,217 | $19.69 | $63K | −5.5% | General Counsel | |
Sep 8, 2025 | URGN | Sell | 1,520 | $19.11 | $29K | −3.4% | General Counsel | |
Jul 28, 2025 | URGN | Sell | 7,522 | $19.14 | $144K | −15.3% | General Counsel |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| URGN | UroGen Pharma Ltd. | 5 | $320K |
Other insiders at UroGen Pharma Ltd.
1 other tracked filer at URGN.